Buckeyes - You are echoing the thoughts I have been saying on this board for the last 3.5 or 4 years. When you put $ figures to all of this it goes so far off the charts that no one listens any more. Whatever BP that ends up winning the purchase of RVX or apabetalone will have the potential to make each of their shareholders buckets of money for many years. If it is RVX that is taken out, the IP library could provide new drug idea foundations for many years into the future. The trial results we are waiting for are not just for us as shareholders but for the extension of life for human kind.

tada